Discontinuation report MINT-FENOFIBRATE E
Report ID | 113175 |
Drug Identification Number | 02465167 |
Brand name | MINT-FENOFIBRATE E |
Common or Proper name | Fenofibrate |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | FENOFIBRATE |
Strength(s) | 145MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 count bottles |
ATC code | C10AB |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-04-24 |
Remaining supply date | 2020-04-24 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-04-25 | French | Compare |
v1 | 2020-04-25 | English | Compare |
Showing 1 to 2 of 2